Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 13/20 | 0.75 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.63 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.63 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.63 |
| ▸ | PLD1 | Q13393 | 6/20 | 0.59 |
| ▸ | PLD2 | O14939 | 4/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11033857 | 0.89 | OPRM1 (0.62) | OPRM1OPRD1OPRK1OPRL1PLD1 | |
| Hydrochloric Acid SCHEMBL11033620 | 0.87 | OPRM1 (0.60) | OPRM1OPRD1OPRK1OPRL1PLD1 | |
| SCHEMBL7961184 | 0.86 | OPRM1 (1.00) | OPRM1OPRD1OPRK1OPRL1PLD1 | |
| SCHEMBL11031960 | 0.85 | OPRM1 (0.62) | OPRM1OPRD1OPRK1OPRL1PLD1 | |
| SCHEMBL11033261 | 0.85 | OPRM1 (0.60) | OPRM1OPRD1OPRK1OPRL1PLD1 | |
| SCHEMBL11031171 | 0.85 | OPRM1 (0.79) | OPRM1OPRD1OPRK1OPRL1PLD1 | |
| SCHEMBL10416342 | 0.83 | OPRM1 (0.68) | OPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL1101959 | 0.83 | OPRM1 (0.77) | OPRM1OPRD1OPRK1OPRL1PLD1 | |
| SCHEMBL10416823 | 0.83 | OPRM1 (0.62) | OPRM1OPRD1OPRK1OPRL1PLD1 | |
| SCHEMBL11031792 | 0.82 | OPRM1 (0.55) | OPRM1OPRD1OPRK1OPRL1PLD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119528878-A | Vascular targeting compounds and medical devices and uses thereof in phototherapy for redness removal | 上海交通大学医学院附属第九人民医院 | 2025-02-28 | — | — | CN | disclosed |